Table 1.
Clinical information of the LC/HCC group and the CC/CH group
| Features | CC%CH | LC%HCC | P value |
|---|---|---|---|
|
Count |
33 |
18 |
- |
|
Antiviral Therapy |
14 (42%) |
3 (17%) |
- |
|
Age (mean ± SD) |
33 ± 10 |
49 ± 12 |
<0.001 |
|
Gender (male%) |
24 (73%) |
14 (78%) |
0.483 |
|
Genotype(C/B) |
23/10 |
11/7 |
0.375 |
|
HBV-DNA > 107copies/ml |
23 (70%) |
9 (50%) |
0.139 |
|
Deletion mutants |
13 (39%) |
7 (39%) |
0.606 |
|
PreS deletion mutants |
6 (18%) |
5 (28%) |
0.325 |
| BCP deletion mutants | 8 (24%) | 3 (17%) | 0.401 |